Latest Avandia news
CYP2C8, SLCO1B1 Variants Impact Response to Rosiglitazone
posted June 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Genetic variants in CYP2C8 and SLCO1B1 impact the therapeutic response to rosiglitazone in patients with type 2 diabetes, according to a study published online June 6 in Diabetes Care.
Addition of Glitazone to Chemo May Help Treat CML
posted September 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Patients with chronic myeloid leukemia who received a glitazone along with imatinib remained disease-free for up to nearly five years in a study published online Sept. 2 in Nature.
Editor's Recommendations
Childhood Cancer Survivors Often Have Mental Distress in Adulthood 
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML 
Acute Myeloid Leukemia Increasingly Impacting Older Adults Globally 
Lower Cognitive Functioning During 60s Linked to Subsequent Stroke Risk 
Nearly 1 in 10 Older Adults Used Cannabis in the Past Year 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
Lower Vertebral Bone Mineral Density Linked to Cognitive Decline Monthly Specialist Briefings
Stay Connected
